{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:26:06Z","timestamp":1787235966861,"version":"build-2736575974"},"reference-count":151,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.tmrv.2020.09.002","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T01:28:14Z","timestamp":1600306094000},"page":"242-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion"],"prefix":"10.1016","volume":"34","author":[{"given":"Roger","family":"Belizaire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Makar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2020.09.002_bb0005","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","author":"G. Trial to Reduce Alloimmunization to Platelets Study","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/vox.12411","article-title":"Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial","volume":"111","author":"Hess","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0015","first-page":"200","article-title":"Relative importance of immune and non-immune causes of platelet refractoriness","volume":"66","author":"Doughty","year":"1994","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0020","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1111\/trf.12739","article-title":"Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion","volume":"54","author":"Rioux-Masse","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00062752-200211000-00009","article-title":"Refractoriness to platelet transfusion","volume":"9","author":"Rebulla","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/MOH.0b013e3282eec526","article-title":"New paradigms in the management of alloimmune refractoriness to platelet transfusions","volume":"14","author":"Vassallo","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness--practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood.V71.2.383.383","article-title":"Clinical factors influencing the efficacy of pooled platelet transfusions","volume":"71","author":"Bishop","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1537-2995.1990.30690333480.x","article-title":"Platelet transfusions administered to patients with splenomegaly","volume":"30","author":"Hussein","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2141.1996.447982.x","article-title":"Clinical and laboratory factors associated with platelet transfusion refractoriness: a case-control study","volume":"93","author":"Alcorta","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0055","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1046\/j.1537-2995.1996.36111297091736.x","article-title":"Influence of antibiotics on posttransfusion platelet increment","volume":"36","author":"Bock","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0060","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI104970","article-title":"Platelet sequestration in man. I. Methods","volume":"43","author":"Aster","year":"1964","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0070","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.V26.6.732.732","article-title":"Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets","volume":"26","author":"Aster","year":"1965","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI105380","article-title":"Pooling of platelets in the spleen: role in the pathogenesis of \"hypersplenic\" thrombocytopenia","volume":"45","author":"Aster","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.RES.8.1.234","article-title":"Immediate effects of intravenous endotoxin on serotonin concentrations and blood platelets","volume":"8","author":"Davis","year":"1960","journal-title":"Circ Res"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0085","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2005-03-0916","article-title":"Platelets express functional Toll-like receptor-4","volume":"106","author":"Andonegui","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0090","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2005-06-2202","article-title":"Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo","volume":"107","author":"Aslam","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0095","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1160\/TH05-01-0009","article-title":"Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor","volume":"94","author":"Ward","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0100","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.4049\/jimmunol.0802884","article-title":"Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4\/MyD88 and the cGMP-dependent protein kinase pathway","volume":"182","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0105","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2015-08-664300","article-title":"Novel phosphatidylethanolamine derivatives accumulate in circulation in hyperlipidemic ApoE-\/- mice and activate platelets via TLR2","volume":"127","author":"Biswas","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/CIRCRESAHA.108.185785","article-title":"Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase","volume":"104","author":"Blair","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0115","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2013-11-536003","article-title":"Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis","volume":"124","author":"Koupenova","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCRESAHA.112.274241","article-title":"Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis","volume":"112","author":"Panigrahi","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1083\/jcb.201111136","article-title":"T granules in human platelets function in TLR9 organization and signaling","volume":"198","author":"Thon","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0130","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.114.013743","article-title":"Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis","volume":"131","author":"Zhang","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/09537104.2018.1445841","article-title":"Platelet Toll-like receptor expression and activation induced by lipopolysaccharide and sepsis","volume":"30","author":"Claushuis","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2141.2008.06999.x","article-title":"Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets","volume":"141","author":"Cognasse","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156977","article-title":"Toll-like receptor signalling is not involved in platelet response to Streptococcus pneumoniae in vitro or in vivo","volume":"11","author":"de Stoppelaar","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2141.1998.00938.x","article-title":"Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets","volume":"103","author":"Sheu","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0160","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/jth.13048","article-title":"The role of platelet MyD88 in host response during gram-negative sepsis","volume":"13","author":"de Stoppelaar","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrmicro1425","article-title":"The interaction of bacterial pathogens with platelets","volume":"4","author":"Fitzgerald","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0170","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1365-2958.2002.02935.x","article-title":"Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A","volume":"44","author":"O'Brien","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0175","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1099\/mic.0.036673-0","article-title":"Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb\/IIIa receptor on platelets","volume":"156","author":"Miajlovic","year":"2010","journal-title":"Microbiology"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0180","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1538-7836.2011.04264.x","article-title":"Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation","volume":"9","author":"Cox","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0185","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0016-5085(03)00397-4","article-title":"Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation","volume":"124","author":"Byrne","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0190","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3324\/haematol.2008.005348","article-title":"Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review","volume":"94","author":"Arnold","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0195","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1365-2141.2002.03612.x","article-title":"Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura","volume":"118","author":"Kohda","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0200","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ajh.21125","article-title":"Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial","volume":"83","author":"Rostami","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0205","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/archinte.164.17.1904","article-title":"Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura","volume":"164","author":"Sato","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0210","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1182\/blood-2009-09-241166","article-title":"P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection","volume":"115","author":"Yeh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0215","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0220","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood-2018-11-844530","article-title":"Neutrophils and NETs in modulating acute and chronic inflammation","volume":"133","author":"Castanheira","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.tmrv.2020.09.002_bb0225","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1096\/fj.201800691R","article-title":"Peptidylarginine deiminase 4: a nuclear button triggering neutrophil extracellular traps in inflammatory diseases and aging","volume":"32","author":"Wong","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0230","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCRESAHA.119.314581","article-title":"Extracellular DNA NET-Works with dire consequences for health","volume":"125","author":"Sorvillo","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0235","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2015-01-624023","article-title":"P-selectin promotes neutrophil extracellular trap formation in mice","volume":"126","author":"Etulain","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0240","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0245","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1182\/blood-2011-01-332676","article-title":"Histones induce rapid and profound thrombocytopenia in mice","volume":"118","author":"Fuchs","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0250","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"von Bruhl","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0255","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1182\/blood-2018-05-850859","article-title":"Cooperative PSGL-1 and CXCR2 signaling in neutrophils promotes deep vein thrombosis in mice","volume":"132","author":"Yago","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0260","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.2053","article-title":"Extracellular histones are major mediators of death in sepsis","volume":"15","author":"Xu","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0265","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-014-0543-8","article-title":"Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation","volume":"18","author":"Ekaney","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0270","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1097\/CCM.0000000000001162","article-title":"Circulating histones are major mediators of cardiac injury in patients with sepsis","volume":"43","author":"Alhamdi","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0275","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1164\/rccm.201206-1037OC","article-title":"Circulating histones are mediators of trauma-associated lung injury","volume":"187","author":"Abrams","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0280","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.2016.0136","article-title":"Histone-associated thrombocytopenia in patients who are critically ill","volume":"315","author":"Alhamdi","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0285","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0290","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br J Cancer"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0295","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/bjh.12757","article-title":"The role of apoptosis in megakaryocytes and platelets","volume":"165","author":"Kile","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0300","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0305","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2011.34.7898","article-title":"Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease","volume":"30","author":"Roberts","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0310","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity","volume":"11","author":"Wilson","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0315","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","article-title":"Programmed anuclear cell death delimits platelet life span","volume":"128","author":"Mason","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0320","doi-asserted-by":"crossref","first-page":"13905","DOI":"10.1074\/jbc.M110.195370","article-title":"BH3-only activator proteins Bid and Bim are dispensable for Bak\/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets","volume":"286","author":"Kodama","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0325","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2141.1997.4813284.x","article-title":"Alterations in Bcl-2\/Bax protein levels in platelets form part of an ionomycin-induced process that resembles apoptosis","volume":"99","author":"Vanags","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0330","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.cdd.4402081","article-title":"Bcl-2 family proteins are essential for platelet survival","volume":"14","author":"Zhang","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0335","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/ml5001867","article-title":"Discovery of a potent and selective BCL-XL inhibitor with in vivo activity","volume":"5","author":"Tao","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0340","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1242\/dev.127.22.4949","article-title":"Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly","volume":"127","author":"Wagner","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0345","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1182\/blood-2012-04-420661","article-title":"Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets","volume":"120","author":"Kraemer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0350","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1172\/JCI95109","article-title":"Protein kinase A determines platelet life span and survival by regulating apoptosis","volume":"127","author":"Zhao","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0355","doi-asserted-by":"crossref","first-page":"E10682","DOI":"10.1073\/pnas.1808217115","article-title":"Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0360","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1084\/jem.20110750","article-title":"Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets","volume":"208","author":"Josefsson","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0365","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjh.14155","article-title":"Loss of PUMA (BBC3) does not prevent thrombocytopenia caused by the loss of BCL-XL (BCL2L1)","volume":"174","author":"Delbridge","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0370","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/cdd.2010.43","article-title":"Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development","volume":"17","author":"Kelly","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0375","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/blood-2009-01-200345","article-title":"Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function","volume":"114","author":"Schoenwaelder","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0380","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tcb.2015.08.003","article-title":"An apoptotic 'eat me' signal: phosphatidylserine exposure","volume":"25","author":"Segawa","year":"2015","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0385","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1432-1033.1982.tb05898.x","article-title":"Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets","volume":"122","author":"Bevers","year":"1982","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0390","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2012.07.036","article-title":"TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation","volume":"151","author":"Yang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0395","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jth.14617","article-title":"Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro","volume":"18","author":"Ji","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0400","article-title":"Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis","volume":"7","author":"Ma","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0405","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1182\/blood-2008-09-180794","article-title":"Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program","volume":"113","author":"Maugeri","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/srep41697","article-title":"Platelet activation determines the severity of thrombocytopenia in dengue infection","volume":"7","author":"Ojha","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0415","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood-2012-09-454314","article-title":"Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation","volume":"121","author":"van Kruchten","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0420","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2017-08-743229","article-title":"Mechanisms of platelet clearance and translation to improve platelet storage","volume":"131","author":"Quach","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0425","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/nm.2030","article-title":"Dual roles for hepatic lectin receptors in the clearance of chilled platelets","volume":"15","author":"Rumjantseva","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0430","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/blood-2009-01-199414","article-title":"Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes","volume":"114","author":"Sorensen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0435","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1073\/pnas.1707662114","article-title":"Sialylation on O-glycans protects platelets from clearance by liver Kupffer cells","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0440","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0049-3848(82)90316-4","article-title":"The loss of sialic acid and its prevention in stored human platelets","volume":"26","author":"Soslau","year":"1982","journal-title":"Thromb Res"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0445","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nm1760","article-title":"The Ashwell receptor mitigates the lethal coagulopathy of sepsis","volume":"14","author":"Grewal","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0450","doi-asserted-by":"crossref","first-page":"20218","DOI":"10.1073\/pnas.1313905110","article-title":"Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor","volume":"110","author":"Grewal","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0455","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/bloodadvances.2020001640","article-title":"Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity","volume":"4","author":"Jansen","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0460","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009","volume":"361","author":"Jain","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0465","article-title":"Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"Li","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0470","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.22211","article-title":"Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbalpha antibodies","volume":"87","author":"Zeng","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0475","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/jth.12524","article-title":"Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study","volume":"12","author":"Peng","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0480","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregates formation trigger tissue factor expression in severe COVID-19 patients","author":"Hottz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0485","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/bjh.16817","article-title":"The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants","volume":"190","author":"Jiang","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0490","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0495","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12863","article-title":"Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor","volume":"7","author":"Deng","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007500","article-title":"Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue","volume":"15","author":"Riswari","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0505","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-017-0476-1","article-title":"Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial","volume":"10","author":"Li","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0510","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0515","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10739680590925493","article-title":"Endogenous mechanisms of inhibition of platelet function","volume":"12","author":"Jin","year":"2005","journal-title":"Microcirculation"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0520","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1161\/CIRCULATIONAHA.106.684852","article-title":"Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia","volume":"116","author":"Rehm","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0525","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0530","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0703393","article-title":"Endothelial dysfunction in diabetes","volume":"130","author":"De Vriese","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0535","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.CIR.101.13.1500","article-title":"Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion","volume":"101","author":"Vink","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0540","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/SLA.0b013e318226113d","article-title":"A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients","volume":"254","author":"Johansson","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0545","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.atherosclerosis.2008.03.024","article-title":"Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation","volume":"202","author":"Nieuwdorp","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0550","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jcrc.2013.04.010","article-title":"Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study","volume":"28","author":"Ostrowski","year":"2013","journal-title":"J Crit Care"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0555","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0560","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nm810","article-title":"Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E","volume":"9","author":"Huo","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0565","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1172\/JCI112200","article-title":"Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines","volume":"76","author":"Bevilacqua","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0570","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1073\/pnas.82.24.8667","article-title":"Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor","volume":"82","author":"Gamble","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0575","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.4049\/jimmunol.137.6.1893","article-title":"Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon","volume":"137","author":"Pober","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0580","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1182\/blood-2008-01-078204","article-title":"The vessel wall and its interactions","volume":"111","author":"Wagner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0585","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.191.8.1413","article-title":"P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo","volume":"191","author":"Frenette","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0590","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1073\/pnas.92.16.7450","article-title":"Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin","volume":"92","author":"Frenette","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0595","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1182\/blood.V91.4.1318","article-title":"Platelet-endothelial interactions in inflamed mesenteric venules","volume":"91","author":"Frenette","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0600","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V92.2.507","article-title":"Platelet-endothelial cell interactions during ischemia\/reperfusion: the role of P-selectin","volume":"92","author":"Massberg","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0605","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1084\/jem.190.6.803","article-title":"The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin","volume":"190","author":"Romo","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0610","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V96.10.3322","article-title":"Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins","volume":"96","author":"Andre","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0615","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor","volume":"84","author":"Savage","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0620","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V94.11.3829","article-title":"Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo","volume":"94","author":"Massberg","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0625","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood-2005-04-1530","article-title":"Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin","volume":"106","author":"Dole","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0630","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.98.12.1164","article-title":"Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells","volume":"98","author":"Gawaz","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0635","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s001340050344","article-title":"Platelet function in septic multiple organ dysfunction syndrome","volume":"23","author":"Gawaz","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0640","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2141.2008.06987.x","article-title":"ADAMTS 13 in non-thrombotic thrombocytopaenic purpura conditions","volume":"141","author":"Scully","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0645","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/bjh.13658","article-title":"Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative","volume":"171","author":"Bendapudi","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0650","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/trf.14181","article-title":"Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency","volume":"57","author":"Li","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0655","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/trf.13654","article-title":"Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study","volume":"56","author":"Li","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0660","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/SHK.0000000000000341","article-title":"ADAMTS-13 in critically ill patients with septic syndromes and noninfectious systemic inflammatory response syndrome","volume":"43","author":"Aibar","year":"2015","journal-title":"Shock"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005468","article-title":"Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis","volume":"11","author":"Birnie","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0670","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3324\/haematol.11677","article-title":"Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor","volume":"93","author":"Bockmeyer","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0675","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1160\/TH09-06-0376","article-title":"Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome","volume":"103","author":"Bongers","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0680","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4269\/ajtmh.2009.80.492","article-title":"ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria","volume":"80","author":"de Mast","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0685","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/j.1538-7836.2007.02743.x","article-title":"ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock","volume":"5","author":"Kremer Hovinga","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0690","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-13-44","article-title":"Deficiency of ADAMTS-13 in pediatric patients with severe sepsis and impact on in-hospital mortality","volume":"13","author":"Karim","year":"2013","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000349","article-title":"Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition","volume":"5","author":"Larkin","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0700","article-title":"Decreased ADAMTS 13 activity is associated with disease severity and outcome in pediatric severe sepsis","volume":"95","author":"Lin","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0705","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1160\/TH09-04-0223","article-title":"Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13","volume":"103","author":"Lowenberg","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0710","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/01.CCM.0000284508.05247.B3","article-title":"Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure","volume":"35","author":"Martin","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0715","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","article-title":"Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure","volume":"107","author":"Ono","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0720","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1537-2995.2007.01126.x","article-title":"How I do it: platelet support for refractory patients","volume":"47","author":"Dzik","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0725","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.1980.03300270023023","article-title":"Aminocaproic acid. Use in control of hemorrhage in patients with amegakaryocytic thrombocytopenia","volume":"243","author":"Gardner","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0730","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/cncr.28253","article-title":"Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies","volume":"119","author":"Antun","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0735","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hon.2189","article-title":"Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series","volume":"34","author":"Marshall","year":"2016","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0740","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"collaborators","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0745","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Collaborators","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0750","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2020.09.002_bb0755","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s13063-019-3663-2","volume":"20","author":"Estcourt","year":"2019","journal-title":"Trials"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796320300456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796320300456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:19:42Z","timestamp":1760138382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796320300456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":151,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0887796320300456"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2020.09.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2020.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}